LOADING
Comparing Eli Lilly and Company (LLY) and Pfizer Inc (PFE), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | PFE |
|---|---|---|
| Price | $1,159.46 | $27.47 |
| Change Today | +1.43% | +0.20% |
| Market Cap | -- | $156.2B |
| P/E Ratio | -- | 36.5 |
| Forward P/E | -- | 9.7 |
| PEG Ratio | -- | 12.89 |
| EPS | -- | $0.75 |
| Revenue Growth (YoY) | -- | 2.6% |
| Profit Margin | -- | 6.8% |
| Return on Equity | -- | 5.0% |
| Dividend Yield | -- | 6.19% |
| Beta | -- | 0.28 |
| 52-Week High | -- | $29.21 |
| 52-Week Low | -- | $22.57 |
| Volume | 75K | 796K |